Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Syros Pharmaceuticals (NQ: SYRS ) 5.800 -0.260 (-4.29%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 48,144 Open 6.100 Bid (Size) 5.500 (10) Ask (Size) 7.000 (6) Prev. Close 6.060 Today's Range 5.770 - 6.100 52wk Range 2.090 - 8.170 Shares Outstanding 20,595,503 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Syros to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024 July 24, 2024 From Syros Pharmaceuticals Via Business Wire Syros to Host Webcast Event on Higher-Risk Myelodysplastic Syndrome and the Opportunity for Tamibarotene to Become the New Frontline Standard-of-Care for Patients with RARA Gene Overexpression June 13, 2024 From Syros Pharmaceuticals Via Business Wire Performance YTD -26.02% -26.02% 1 Month -0.17% -0.17% 3 Month +14.40% +14.40% 6 Month -12.52% -12.52% 1 Year +64.77% +64.77% More News Read More SYRS Stock Earnings: Syros Pharmaceuticals Beats EPS for Q1 2024 May 14, 2024 Via InvestorPlace Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update May 14, 2024 From Syros Pharmaceuticals Via Business Wire Syros Pharmaceuticals's Earnings Outlook March 26, 2024 Via Benzinga Syros to Participate in Upcoming Investor Conferences May 07, 2024 From Syros Pharmaceuticals Via Business Wire Syros to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024 May 07, 2024 From Syros Pharmaceuticals Via Business Wire Crude Oil Down Over 1%; Cognyte Software Shares Plummet April 09, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 12 Health Care Stocks Moving In Tuesday's Intraday Session April 09, 2024 Via Benzinga Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 09, 2024 Via Benzinga Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression April 09, 2024 From Syros Pharmaceuticals Via Business Wire Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 02, 2024 From Syros Pharmaceuticals Via Business Wire Top 3 Health Care Stocks You'll Regret Missing This Month April 02, 2024 Via Benzinga SYRS Stock Earnings: Syros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 March 27, 2024 Via InvestorPlace Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update March 27, 2024 From Syros Pharmaceuticals Via Business Wire Earnings Scheduled For March 27, 2024 March 27, 2024 Via Benzinga Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial March 25, 2024 From Syros Pharmaceuticals Via Business Wire Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024 March 20, 2024 From Syros Pharmaceuticals Via Business Wire A Look Into Healthcare Sector Value Stocks March 11, 2024 Via Benzinga Syros to Participate in TD Cowen 44th Annual Health Care Conference February 27, 2024 From Syros Pharmaceuticals Via Business Wire Overview Of Value Stocks In The Healthcare Sector February 12, 2024 Via Benzinga 3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential January 31, 2024 Via InvestorPlace 5 Value Stocks To Watch In The Healthcare Sector January 29, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session January 09, 2024 Via Benzinga Syros Highlights Anticipated 2024 Milestones to Deliver on the Value of Tamibarotene January 08, 2024 From Syros Pharmaceuticals Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.